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OBJECTIVES: To compare screening practices and
beliefs in patients with and without a clinically impor-
tant family history.
DESIGN: We mailed a brief questionnaire asking about
family history and a second, longer survey asking about
knowledge of and beliefs about colorectal cancer to all
respondents with a family history and a random sample
of respondents without a family history of colorectal
cancer. We reviewed electronic medical records for
screening examinations and recording of family history.
PARTICIPANTS: One thousand eight hundred seventy
of 6,807 randomly selected patients ages 35–55 years
who had been continuously enrolled in a large multi-
specialty group practice for at least 5 years.
MEASUREMENTS: Recognition of increased risk,
screening practices, and beliefs—all according to
strength of family history and patient’s age.
RESULTS: Nineteen percent of respondents reported a
family history of colorectal cancer. In 11%, this history
was strong enough to warrant screening before age
50 years. However, only 39% (95% CI 36, 42) of
respondents under the age of 50 years said they had
been asked about family history and only 45% of those
with a strong family history of colorectal cancer had
been screened appropriately. Forty-six percent of
patients with a strong family history did not know that
they should be screened at a younger age than average
risk people. Medical records mentioned family history of
colorectal cancer in 59% of patients reporting a family
history.
CONCLUSIONS: More efforts are needed to translate
information about family history of colorectal cancer
into the care of patients.
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INTRODUCTION
Colorectal cancer is a leading cause of cancer death, both in
the US and throughout the world. There is strong evidence
that this cancer can be prevented and screening is recom-
mended in clinical practice guidelines.
1–3 However, screening
rates are low. Only 57.3% of US adults were screened by
currently recommended standards in 2004.
4
Family history is a major risk factor for colorectal cancer.
Incidence is increased in relation to the number of family
members with this cancer, whether they are first- or second-
degree relatives, and early age of onset.
5–7 Clinical practice
guidelines match the aggressiveness of screening recommen-
dations to the strength of the family history
3. However, little is
known about how these recommendations have been imple-
mented in the care of patients.
8
We studied patients with a family history of colorectal
cancer in a large multispecialty group practice and compared
their care to that of patients without this family history. We
describe the prevalence of family history according to its
strength, whether family history was identified at a time when
screening should have been started, and whether this knowl-
edge led to appropriate screening. We also describe patients’
beliefs and attitudes concerning family history in relation to
their risk and screening experience.
METHODS
Design. We surveyed a random sample of patients about their
family history of colorectal cancer, screening experiences, and
demographic characteristics. We then sent a follow-up survey
asking about attitudes, knowledge, and beliefs concerning
colorectal cancer and the consequences of having a family
member with this cancer. Finally, we reviewed electronic
medical records to assess screening and agreement between
patients’ reports of family history and information in the
medical records. This study was approved by the Committee
for the Protection of Human Subjects at Harvard Pilgrim
Health Care.
Setting. Our study took place at Harvard Vanguard Medical
Associates (HVMA), a multispecialty group practice in the
Greater Boston area that is responsible for the heath care of
about 300,000 patients. At the time of the study, HVMA was
comprised of 14 practices with 160 primary care physicians (for
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508care of adults, mostly general internists) who were responsible
for initiating screening and 12 gastroenterologists. Primary and
specialty care is integrated through shared electronic medical
records, formulary, guidelines,email communications, physical
proximity within practices, and administrative structure.
Preventive health care has been a priority at HVMA since it
was founded as a staff model HMO in 1969.
Population and Sample. As of January 1, 2004, 31,959
patients were 35–55 years old, continuously enrolled at
HVMA for the past 5 years, insured by HVMA’s main insurer
(Harvard Pilgrim Health Care), and met the following criteria:
no record of conditions that might have led to lower
gastrointestinal endoscopy (such as intestinal cancer,
inflammatory bowel disease, recent gastroenteritis or colitis,
evidence of intestinal blood loss, or other disorders of the
intestine); no conditions that might have precluded responding
to the survey; no “sensitive” diagnoses (such as substance
abuse or HIV infection); and not on a list of patients who had
requested that they be excluded from all survey research at
HVMA. We included patients <40 years old because some
guidelines recommend that screening begin 10 years before
onset in the family member and to provide a context for
interpreting screening in increased risk patients. Sample
selection and participation in subsequent stages of the study
are summarized in Figure 1.
Survey Data Collection. In February 2004, we sent a mailed
questionnaire to a random sample of 7,000 of the 31,959
members who met inclusion criteria. This initial survey asked
about: family history (all blood relatives who had been
diagnosed with colorectal cancer, their relationship to the
respondent, and their age(s) of onset); screening history,
including whether their physician had ever asked if a family
member had colon or rectal cancer or had recommended
screening; and demographic characteristics. We sent a
reminder post card to all nonresponders 2 months after the
initial mailing and closed this phase of data collection 6 months
after the surveys were first mailed. None of the responding
patients met usual criteria for the autosomal dominant
syndromes, Hereditary Nonpolyposis Colon Cancer and
Familial Adenomatous Polyposis, which are associated with
an unusually high risk of colorectal and (in the case of HNPCC)
other cancers and more aggressive screening than in patients
with a simple family history.
Six months after we sent the initial survey, we mailed a follow-
up survey to the 355 patients who had reported a family history
of colorectal cancer, and a random sample of 710 who had not
reported a family history, on the initial survey. We chose an
interval of 6 months between surveys to allow enough time for
responses to the initial survey and to minimize the effect of the
first survey on responses to the second. The follow-up question-
naire asked about patients’ knowledge of colorectal cancer
prevention in general, whether they believed it runs in families,
their perception of their own risk, knowledge of screening tests,
their own colorectal cancer screening history, their intentions for
screening in the future, and attributes of screening tests that
mattered most to them. Questions were adapted from existing,
validated instruments.
9–12 We resent the survey to patients who
Figure 1. Sample selection and participation according to stage of
the study.
Table 1. Characteristics of Respondents to the Initial Survey and
Comparison to Nonrespondents
Characteristic Respondents
(N=1,870)
Nonrespondent
(N=4,937)*
Number
† % Number %
Age (years)
‡
35–39 260 13.9 984 19.9
40–44 362 19.4 1,199 24.3
45–49 480 25.7 1,280 25.9
50–55 766 41.0 1,474 29.9
Sex
‡
Female 1,129 60.4 2,572 52.1
Male 739 39.6 2,365 47.9
Race/ethnicity
‡
Caucasian 1,138 86.6 2,120 72.0
Black 139 10.6 621 21.1
Asian 16 1.2 72 2.5
Hispanic 21 1.6 129 4.4
Native American 0 0 1 0.0
Education
Some high school 25 1.3
GED or HS diploma 128 6.8
Some college courses 276 14.8
College degree 1,439 77.0
Household income ($)
<20,000 24 1.3
20,000–34,000 77 4.1
35,000–49,000 154 8.2
50,000–74,000 415 22.2
>75,000 1119 59.8
*Education and household income were obtained from the survey and
are not available for nonrespondents
†Numbers do not total 1,870 in some rows because of missing data
‡P value for respondents versus nonrespondents ≤.001
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responses received within 4 months of the initial mailing.
Medical Record Review. To assess whether, when, and how
patients had been screened, we searched the electronic
medical records of all patients who returned the follow-up
survey for a set of codes for screening for colorectal cancer by
fecal occult blood test, sigmoidoscopy, colonoscopy, and
barium enema recorded in the 10 years before the initial
survey. Patient self-reports were not used as the standard for
whether screening took place.
Of 833 participants who completed the follow-up survey, 373
gave permission for us to review their medical records specif-
ically for family history. To assess whether family history had
been recorded in the medical record, we performed a text word
search on the 357 of these 373 records we could locate (96%).
We created an algorithm that included the presence of various
synonyms for family, relatives, or their abbreviations as well as
synonyms or their abbreviations for colorectal cancer, both
recorded in the same visit. The algorithm also identified
patients who had the code for “family history of colorectal
cancer” in their problem list. The algorithm flagged 163 of the
357 available records as containing family history information.
One of us (RF) reviewed all flagged records and coded family
history as present in the medical record if the review confirmed
the algorithm. All records not flagged by the algorithm, or
flagged incorrectly (relative to the review) as positive were coded
as not containing a family history of colorectal cancer.
Definitions of Variables. We grouped respondents’ strength of
family history into one of four mutually exclusive categories:
strong, intermediate, weak, and no family history (see Table 2
for definitions). These categories are consistent with the risk
stratification recommended in current clinical practice
guidelines.
3
We defined appropriate screening tests according to local
(HVMA) guidelines: for strong family history, colonoscopy
beginning at age 40 and repeated every 5 years; for interme-
diate family history, screening beginning at age 40 years with
flexible sigmoidoscopy every 5 years and fecal occult blood test
(FOBT) every year, colonoscopy every 10 years, or double
contrast barium enema every 5 years; for weak or no family
history, these same tests, at the same interval as for interme-
diate risk patients, but starting at age 50 years. The local
standards were comparable to national guidelines for patients
with family history of colorectal cancer but more stringent for
average risk patients, for whom either FOBT or sigmiodoscopy,
not necessarily both, are usually recommended. We took three
FOBTs in 5 years to be adequate screening, instead of one
every year, to allow for the common practice of scheduling
FOBTs after each year’s anniversary.
Statistical Analyses. Data from surveys and medical records
were linked and analyzed using SAS version 8.2. The main
results were descriptive statistics and contingency tables
relating screening experiences to strength of family history
and age. Analyses of screening took into account the
recommended interval between screening examinations and
how choice of test and interval differed according to strength of
family history. The Chi-square statistic was used to calculate
P-values for proportions the binomial distribution to estimate
confidence intervals.
RESULTS
We sent initial surveys to 7,000 patients, 193 of which were
returned because of wrong addresses. Of the remaining 6,807,
1,870 were returned, for a response rate of 27.5%; 1,854
provided adequate family history information. Of the 1,065
members sent the follow-up survey, 833 (78.2%) returned
useable surveys. Excluding 66 patients who declined further
participation in the study, 372 of 767 (48.5%) asked gave
permission to review their medical records for family history
information. Figure 1 summarizes the number of patients
participating at each stage of this study.
The characteristics of respondents to the initial survey are
summarized in Table 1 and compared with patients in the
original sample who did not respond. Respondents were more
likely to be older, female, and white. The demographic
characteristics of respondents to the follow-up survey were
similar to those of respondents to the initial survey.
Table 2. Prevalence of Family History of Colorectal Cancer Age
35 – 55 Years According to Strength of Risk (N=1,854*)
Strength of
History
Definition Number of
patients
Percentage
Strong 1st degree relative with
onset at age ≤60 years
or 2 or more 1st degree
relatives at any age
53 2.9
Intermediate 1st degree relative with
onset at age 60 or
more years or 2 or
more 2nd degree
relatives
162 8.7
Other Other family history
of colorectal cancer
140 7.6
None No family history of
colorectal cancer
1,499 80.9
Total 1,854 100.1
*Twelve patients responded to the initial survey but did not provide
complete information on family history of colorectal cancer
Figure 2. Age at which respondents thought they should begin
screening for colorectal cancer according to strength of family
history (N=833).
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reported a family history of colorectal cancer (Table 2). Family
history was clinically important in the 11.6% with strong or
intermediate strength history, in that, according to guidelines,
it should have prompted screening before age 50 years. The
prevalence of clinically important family history, increased
with the age of the respondent, from 4.7% for patients aged
35–39 years to 18.6% by age 55 years (P<0.001). For a
substantial proportion of patients with a family history of
colorectal cancer in our sample, this risk factor would have
become apparent only after age 50, too late to implement
recommendations for early screening.
Beliefs. Beliefs about colorectal cancer differed according to
strength of family history but not age. Over 97% of respondents
reporting a family history of colorectal cancer, regardless of
strength of the history, believed that “colon cancer is a type of
cancer that runs in families” while fewer (75%) of those who did
not report colorectal cancer in their own family agreed. Over half
of respondents with a clinically important (strong or intermediate
strength) family history (59% in both groups) thought that they
were more likely to get colon cancer compared with other people of
the same age and race, whereas few respondents without a family
history of colorectal cancer (less than 5%, regardless of age)
believed they were at increased risk. Most patients with a family
history agreed with the assertion that “family and friends think I
should be screened for colon cancer.” This belief was directly
related to strength of family history and was strongest (95%
agreement) in respondents with a strong family history who were
under age 50 years.
Many patients with a family history of colorectal cancer did
not know that they should begin screening earlier than average
risk patients (Fig. 2). Almost half of respondents in the strong
risk category (18/39=46%) incorrectly believed that they
should begin screening at age 50 years, whether or not they
were themselves over 50 years old. On the other hand, a
substantial proportion of respondents with no family history of
colorectal cancer believed they should be screened before age
50 years: 24.9% of average risk respondents believed they
should begin screening at age 40 years and 4.5% thought they
should begin screening at age 30 years
Identification of Risk. Of 1,041 respondents younger than age
50 years, 407 (39.1%, 95% CI 36.1%, 42.0%) reported that
their clinician had asked if a family member had colon or rectal
cancer. In contrast, 72.2% (95% CI 70.0, 76.4) of respondents
age 50 years or older said they had been asked.
Appropriate Screening. For the 29 persons with a strong family
history who were less than 50 years old, 13 (45%) were screened
before age 50 years with colonoscopy. Screening rates in
patients with a strong family history were higher (18/24, 75%)
over age 50 years (P for difference in screening rates by
age=0.03). A similar pattern was seen for patients with an
intermediate strength family history: only 16 of 69 (23%)
under age 50 had been screened appropriately, whereas 71
of 93 (76%) patients age 50 years or older had been
screened (P<0.001). When patients with strong or
intermediate family history of colorectal cancer were
screened before age 50 years, it was predominantly with
colonoscopy. For patients 50–55 years old, appropriate
screening rates were similar for patients with weak and
with no family history (49 and 41%, respectively, P=0.10).
Agreement Between Patients’ Reports of Family History and
Medical Records. Among the 357 study patients who gave
permission for us to examine their medical records, 136 had
reported a family history of colorectal cancer on the survey and
80 of these had that information recorded in their electronic
medical record. Taking patient report as the “gold standard” for
accuracy, review of the medical record had a sensitivity of 59%
and a specificity of 95% for detecting this family history. One of
the authors (MB) interviewed patients who had not reported
family history of colorectal cancer on the survey but had this
history recorded in their medical record. Most (eight out of ten)
still thought that they did not have a family history of
colorectal cancer and could explain why family history was
(incorrectly) mentioned in the medical record.
If family history was mentioned in the medical record at all,
it was likely to be accompanied by information about the
relative’s relationship (86/90=96%) but less likely to include
information about the relative’s age of onset (49/90=54%).
This additional information was no more or less likely to be
present in patients with high and intermediate risk than in
those with weak family history of colorectal cancer.
Screening Test Preference. We asked patients to choose three
of nine test characteristics that mattered most to them.
Regardless of family history, respondents chose, in descending
order of importance: accuracy, pain and discomfort, risk of
complications, invasiveness, time for the procedure, waiting
time, embarrassment, cost, and doing the test at home (Fig. 3).
Respondents with a strong or intermediate family history of
colorectal cancer believed that accuracy mattered more and
Figure 3. Screening test characteristics that matter most to patients,
in order of importance, according to strength of family history
(N=825).
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compared with patients with weak or no such family history
(P for each comparison <.05).
DISCUSSION
The study setting has many characteristics that are believed to
favor screening. Nevertheless, most respondents had not been
asked about family history of colorectal cancer in time to begin
screening if that history were present. Patients with a strong
family history of colorectal cancer generally knew that this cancer
runs in families, believed they were at increased risk, and thought
that family and friends wanted them to be screened, but did not
know that screening should begin before age 50 years. A review of
electronic medical records would not have detected many of the
patients at increased risk because the relevant data were not
recorded. It is not surprising then that only half the patients with
a strong family history were screened appropriately.
Our study adds to a small literature on patient preferences
for colorectal cancer screening tests.
13–16 We found, as Ling
did,
13 that accuracy and discomfort were most important
whereas inconvenience was less important to patients.
Respondents with a strong or intermediate family history
expressed similar preferences but accuracy was even more
important and pain, risk of complications, and invasiveness
less important to them. These are distinguishing character-
istics of colonoscopy, the test recommended for such patients,
suggesting that recommendations are consistent with patients’
preferences, perhaps increasing the likelihood of adherence.
We had little opportunity to explore the effect of costs on
preferences, as Pignone did,
14 because most respondents in
our study were insured for all screening test options.
The shortfalls we observed are consistent with direct obser-
vation of care by primary care physicians in the community
17
and with studies of physicians’ knowledge, beliefs, and stated
practices.
18–20 Barriers to family history taking in primary care
have been described, including lack of time, reimbursement
policies that are inconsistent with this activity, and clinicians’
perceptions that their knowledge and skills are not up to
date
8,21, and these may have accounted for some of our findings.
Response rate to the initial survey was relatively low and
respondents were a biased sample of the underlying population,
in that they were older and more often female and white. As a
result, our estimates of family history prevalence, as well as
patients’ beliefs, preferences, and care might have misrepre-
sented those of less selected adults in our setting. It is reassuring
in this regard that the prevalence of family history found in our
study was similar to that found in studies of the general
population
22 and in the PLCO trial.
23 Nevertheless, we cannot
rule out the possibility that selection biasaffectedour results nor
can we estimate the magnitude and direction of potential bias.
Our study had several other limitations. We did not ask
about family history of colorectal adenomas, also a risk factor
for colorectal cancer.
24 We did not measure comorbidity, a
reason for not pursuing screening in some patients. Although
we searched medical records for 10 years before the initial
survey, some colonoscopies may have been missed in patients
who had not been in the practice beyond 5 years. We did not
validate patients’ reports of family history against external
sources, such as hospital records and the death certificates;
however, patients’ reports of family history of colorectal cancer
have been shown to be relatively accurate.
25 The initial survey
may have affected responses to the follow-up survey, especially
for participants with a family history, although the two surveys
were 6 months apart.
On the other hand, the study has important strengths. By
stratifying results by strength of risk and by age, we were able
to examine effects at the level of specificity set out in most
clinical practice guidelines. Also, we were able to describe
patients’ attitudes, knowledge, and beliefs in relation to the
level of their familial risk and screening. We could rely on
medical record data when determining screening practices.
More attention to family history and more effective ways of
integrating it into practice are needed.
26,27 Whatever gains are
made for familial colorectal cancer should be applicable to
other conditions, such as breast and prostate cancer, cardio-
vascular disease, and diabetes, for which risk in adult life and
screening practices also depend on whether close relatives
have developed these conditions at a relatively early age.
Acknowledgments: This work was supported by grant No. 1 R21
CA102381-01 from the National Cancer Institute, National Institutes
of Health.
Conflicts of Interest: None disclosed.
Corresponding Author: Robert H. Fletcher, MD, MSc; 208 Boulder
Bluff, Chapel Hill, NC 27516, USA (e-mail: Robert_Fletcher@hms.
harvard.edu).
REFERENCES
1. U.S. Preventive Services Task Force. Screening for colorectal cancer:
recommendations and rationale. Ann Intern Med. 2002;137:129–31.
2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines
for the early detection of cancer, 2005. CA Cancer J Clin. 2005;55:31–44.
3. Winawer S, Fletcher RH, Rex D, et al. Colorectal cancer screening and
surveillance: clinical guidelines and rationale—update based on new
evidence. Gastroenterology. 2003;124:544–60.
4. Centers for Disease Control and Prevention (CDC). Increased use of
colorectal cancer tests—United States, 2002 and 2004. Morb Mort Wkly
Rep. 2006;55:308–11.
5. Johns LE, Houlston RS. A systematic review and meta-analysis of
familial cancer risk. Am J Gastroenterol. 2001;96:2992–3003.
6. Slattery ML, Kerber RA. Family history of cancer and colon cancer risk:
the Utah Population Database. J Natl Cancer Inst. 1994;86:1618–26.
7. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE,
Willett WC. A prospective study of family history and the risk of
colorectal cancer. New Engl J Med. 1994;331:1669–74.
8. Rich EC, Burke W, Heaton CJ, et al. Reconsidering the family history in
primary care. J Gen Intern Med. 2004;19:273–80.
9. Jacobs LA. Health beliefs of first-degree relatives of individuals with
colorectal cancer and participation in health maintenance visits: a
population-based survey. Cancer Nurs. 2002;25:251–65.
10. Lipkus IM, Samsa GP, Dement J, et al. Accuracy of self-reports of fecal
occult blood tests and test results among individuals in the carpentry
trade. Prev Med. 2003;37:513–9.
11. Rakowski W, Fulton JP, Feldman JP. Women’s decision making about
mammography: a replication of the relationship between stages of
adoption and decisional balance. Health Psychol. 1993;12:209–14.
12. Vernon SW, Myers RE, Tilley BC. Development and validation of an
instrument to measure factors related to colorectal cancer screening
adherence. Cancer Epidemiol Biomarkers Prev. 1997;6:825–32.
13. Ling BS, Moskowitz MA, Pearson B, Schroy Paul C III. Attitude toward
colorectal cancer screening tests. A survey of patients and physicians. J
Gen Intern Med. 2001;16:822–30.
512 Fletcher et al.: Screening and Family History of Colorectal Cancer JGIM14. Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer
screening. J Gen Intern Med. 1999;14:432–7.
15. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal
cancer screening. J Fam Pract. 1997;45:211–8.
16. Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient
preferences and adherence to colorectal cancer screening in an urban
population. Am J Public Health. 2006;96:809–11.
17. Acheson LS, Weisner GL, Zyzanski SJ, Goodwin MA, Stange KC.
Family history-taking in community family practice: implications for
genetic screening. Genet Med. 2000;2(3):180–5.
18. Schroy PC 3rd, Barrison AF, Ling BS, Wilson S, Geller AC. Family
history and colorectal cancer screening: a survey of physician knowledge
and practice patterns. Am J Gastroenterol. 2002;97:1013–6.
19. Acton RT, Burst NM, Casebeer L, et al. Knowledge, attitudes, and
behaviors of Alabama’s primary care physicians regarding cancer
genetics. Acad Med. 2000;75:850–2.
20. Hayflick SJ, Eiff MP, Carpenter L, Steinberger J. Primary care
physicians’ utilization and perceptions of genetic services. Genet Med.
1998;1:13–21.
21. Suther S, Goodson P. Barriers to the provision of genetic services by
primary care physicians: a systematic review of the literature. Genet Med.
2003;5:70–6.
22. Michell RJ, Campbell H, Farrington SM, Brewster DH, Porteus ME,
Dunlop MG. Prevalence of family history of colorectal cancer in the
general population. Br J Surg. 2005;92:1161–4.
23. Pinsky PF, Kramer BS, Reding D, Buys S, for the PLCO Project Team.
Reported family history of cancer in the prostate, lung, colorectal cancer,
and ovarian cancer screening trial. Am J Epidemiol. 2003;157:792–9.
24. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in
families of patients with adenomatous polyps. N Engl J Med. 1996;
334:82–7.
25. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history
of cancer? An evidence-based analysis of the accuracy of family cancer
history. JAMA. 2004;292:1480–9.
26. Guttmacher AE, Collins FS, Carmona RH. The family history—more
important than ever. N Engl J Med. 2004;351:2333–6.
27. Burke W. Taking family history seriously. Ann Intern Med. 2005;
143:388–9.
513 Fletcher et al.: Screening and Family History of Colorectal Cancer JGIM